Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study
The Lancet Respiratory Medicine | Apr 02, 2019
Darolutamide in nonmetastatic, castration-resistant prostate cancer
New England Journal of Medicine | Apr 01, 2019
Biomarkers associated with response to regorafenib in patients with hepatocellular carcinoma
Gastroenterology | Apr 01, 2019
Modifying effect of statins on fatal outcomes in chronic kidney disease patients in the Systolic Blood Pressure Intervention Trial: A post hoc analysis
American Journal of Nephrology | Apr 01, 2019
Role of targeted therapy and immune checkpoint blockers in advanced non-small cell lung cancer: A review
The Oncologist | Mar 31, 2019
Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: Integrated results from phase 3, randomized, placebo-controlled, PIONEER trials
British Journal of Dermatology | Mar 31, 2019
Anti-dementia medication use by aged care residents with dementia
International Journal of Geriatric Psychiatry | Mar 30, 2019